Overview

Safety and Efficacy of Tissue Plasminogen Activator (tPA) in Neonates and Infants

Status:
Terminated

Trial end date:
2012-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if alteplase is effective in dissolving a clot in a catheter in a large vein (central venous line or PICC line) or artery in infants less than 6 months of age.

Phase:

Phase 1

Details

Lead Sponsor:

University of Louisville

Collaborator:

Genentech, Inc.

Treatments:

Tissue Plasminogen Activator